- Home
- CYBN vs FLYX Comparison
CYBN vs FLYX Comparison
Compare CYBN & FLYX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CYBN
- FLYX
- Stock Information
- Founded
- CYBN 2019
- FLYX 2015
- Country
- CYBN Canada
- FLYX United States
- Employees
- CYBN N/A
- FLYX N/A
- Industry
- CYBN Pharmaceuticals and Biotechnology
- FLYX Blank Checks
- Sector
- CYBN Health Care
- FLYX Finance
- Exchange
- CYBN Nasdaq
- FLYX Nasdaq
- Market Cap
- CYBN 207.5M
- FLYX 175.8M
- IPO Year
- CYBN N/A
- FLYX N/A
- Fundamental
- Price
- CYBN $9.42
- FLYX $2.50
- Analyst Decision
- CYBN Strong Buy
- FLYX Hold
- Analyst Count
- CYBN 3
- FLYX 1
- Target Price
- CYBN $138.00
- FLYX N/A
- AVG Volume (30 Days)
- CYBN 314.1K
- FLYX 14.7K
- Earning Date
- CYBN 02-12-2025
- FLYX 01-01-0001
- Dividend Yield
- CYBN N/A
- FLYX N/A
- EPS Growth
- CYBN N/A
- FLYX N/A
- EPS
- CYBN N/A
- FLYX N/A
- Revenue
- CYBN N/A
- FLYX $311,873,000.00
- Revenue This Year
- CYBN N/A
- FLYX $15.91
- Revenue Next Year
- CYBN N/A
- FLYX $39.64
- P/E Ratio
- CYBN N/A
- FLYX N/A
- Revenue Growth
- CYBN N/A
- FLYX N/A
- 52 Week Low
- CYBN $6.50
- FLYX $1.79
- 52 Week High
- CYBN $19.84
- FLYX $24.21
- Technical
- Relative Strength Index (RSI)
- CYBN 40.07
- FLYX 52.29
- Support Level
- CYBN $9.50
- FLYX $2.04
- Resistance Level
- CYBN $10.06
- FLYX $2.67
- Average True Range (ATR)
- CYBN 0.57
- FLYX 0.21
- MACD
- CYBN -0.13
- FLYX 0.03
- Stochastic Oscillator
- CYBN 11.44
- FLYX 49.05
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.
About FLYX flyExclusive Inc.
flyExclusive Inc is an owner and operator of curated private aviation experiences dedicated to surpassing passenger expectations for quality, convenience, and safety. Its mission is to be the world's majority vertically integrated private aviation company through capital-efficient program growth, an industry pricing model, optimal dispatch availability, in-house training, and a controlled premium customer experience on modernized aircraft. The company has over 90 aircraft in its owned and leased fleet which includes light, midsize, super-midsize, and large jets. As one of the nation's Citation operators, it has curated a versatile fleet of Citation CJ3/CJ3 plus, Citation Excel/XLS/XLS plus, Citation Encore/Encore plus, Citation Sovereign, and Citation X aircraft.